ENOD2A (P08297; early nodulin-75 / N-75 / NGm-75) is a soybean "early nodulin", one of a pair of nearly identical, tandemly arranged genes (ENOD2A and ENOD2B) encoding the same proline-rich protein. It is a 309-residue secreted precursor with an N-terminal signal peptide (residues 1-25) and a long, disordered, very proline-rich mature region built almost entirely from pentapeptide repeats (variants of Pro-Pro-x-Tyr/His-Lys rich in Glu/Lys), the hallmark architecture of the hydroxyproline-rich/proline-rich cell-wall glycoprotein (HRGP/extensin) class. ENOD2 is therefore best understood as a secreted, (hydroxy)proline-rich STRUCTURAL cell-wall protein, not an enzyme, transporter or signalling molecule. Its defining feature is spatially and temporally restricted expression: ENOD2 mRNA appears early in nodule development (detectable ~day 6, strong by ~day 10, before nitrogen fixation) and in situ hybridisation localises it predominantly to the nodule inner cortex / nodule parenchyma, plus cells surrounding the connecting vascular bundle that links the determinate nodule to the root central cylinder (van de Wiel et al. 1990). The nodule parenchyma is the tissue layer associated with the steep oxygen-concentration gradient that protects oxygen-sensitive nitrogenase, and the prevailing (but inferential) hypothesis is that ENOD2 contributes structurally to the specialized cell walls / morphology of this layer and possibly to its oxygen-diffusion- barrier properties. Importantly, ENOD2 is a classic early-nodulin MARKER gene defined by its nodule-specific expression rather than by any demonstrated mechanistic role in the Nod-factor signalling or nodule-organogenesis program; no loss-of-function genetics exists for soybean ENOD2, and a later synthesis (Foster 1998) notes ENOD2 is "unlikely to be solely responsible" for nodule oxygen regulation. Consequently the legacy "nodulation" annotation is best read as an expression-derived over-annotation, while the genuinely supported core nature of the protein is a nodule-parenchyma cell-wall structural glycoprotein localised to the apoplast/extracellular region.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0005737 cytoplasm | IBA GO_REF:0000033 | MODIFY | Summary: IBA annotation propagated across the PANTHER proline-rich cell-wall protein group (PTN007993732). It places ENOD2 in the cytoplasm, which directly contradicts the best-supported localisation: ENOD2 is a SECRETED protein with an N-terminal signal peptide that is targeted to the apoplast / cell wall. Reason: "Cytoplasm" is almost certainly incorrect for ENOD2 and is a poor phylogenetic propagation for a secreted cell-wall protein. The UniProt entry annotates a signal peptide over residues 1-25 (SIGNAL 1..25) and a long disordered, proline-rich mature chain, and the protein belongs to the hydroxyproline-rich/proline-rich cell-wall protein class. The deep-research synthesis concludes the best-supported localisation is the secretory pathway leading to the apoplast/cell wall, based on the proline-rich repeat architecture and the predicted N-terminal signal peptide. An intracellular cytoplasmic location is inconsistent with these features. The annotation should be MODIFIED to the correct extracellular/cell-wall localisation. Because no direct protein-localisation experiment for soybean ENOD2 was retrievable (only sequence-based and tissue-level evidence), the conservative supported replacement is the broad "extracellular region" (GO:0005576), with the more specific apoplast (GO:0048046) and plant-type cell wall (GO:0009505) as additional candidate locations supported by the protein class. Supporting Evidence: file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md A **putative N-terminal signal peptide** is reported from ENOD2 gene sequence analysis, consistent with secretion into the apoplast and association with the cell wall. file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md the best-supported localization with the available evidence is: **secretory pathway → apoplast/cell wall** in **nodule parenchyma (inner cortex) cells** and cells associated with the nodule-root vascular connection. UniProtKB:P08297 SIGNAL 1..25 |
| GO:0009877 nodulation | IEA GO_REF:0000043 | MARK AS OVER ANNOTATED | Summary: SPKW (GO_REF:0000043) annotation derived from the UniProt keyword "Nodulation"; snapshot-only, removed in the current GOA release. ENOD2 is a classic "early nodulin" MARKER, defined by nodule-specific EXPRESSION (inner cortex / nodule parenchyma) of a proline-rich cell-wall protein, rather than by a demonstrated mechanistic role in the nodulation signalling or organogenesis program. Reason: GOA's removal of this annotation was JUSTIFIED. "Nodulation" (GO:0009877) here is an expression-not-function over-annotation. The evidence base for ENOD2 is dominated by transcript localisation: in situ hybridisation localises ENOD2 mRNA predominantly to the nodule inner cortex / nodule parenchyma and to cells around the connecting vascular bundle, and it is detectable early (~day 6, strong by ~day 10) before nitrogen fixation. This nodule-restricted EXPRESSION earned the SwissProt "Nodulation" keyword, but ENOD2 is a secreted, very proline-rich (hydroxyproline-rich) STRUCTURAL cell-wall protein, and its proposed contribution to nodulation is an inferential structural role ("may contribute to the special morphology of nodule parenchyma cells", possibly to the oxygen-diffusion barrier) - not a demonstrated function in the developmental/signalling process. There is no loss-of-function genetics for soybean ENOD2, and a later synthesis notes ENOD2 is "unlikely to be solely responsible" for nodule oxygen regulation. Because the gene's actual nature (a parenchyma cell-wall structural glycoprotein) is better captured by structural / cell-wall / extracellular terms (see the NEW entries below and the MODIFY on cytoplasm), the broad process term "nodulation" - assigned purely from an expression-derived keyword - is an over-annotation and its removal is appropriate. (It is not flatly wrong - ENOD2 IS a nodule-specific gene - hence MARK_AS_OVER_ANNOTATED rather than REMOVE.) Supporting Evidence: file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md ENOD2’s most concrete “application” is as a **molecular marker** of nodule parenchyma/inner cortex differentiation and early nodule development, supported by its strong and specific localization pattern in soybean nodules. file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md an “early nodulin” encoding a **very proline-rich protein with repeating pentapeptides** and sequence features consistent with a **secreted hydroxyproline-rich cell-wall protein precursor**. file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md Review summarizes evidence that ENOD2 is cell-wall associated and may influence structure, but notes some cited studies argue against a strict oxygen-regulation role file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md This remains a **hypothesis based on localization + protein class**, not a demonstrated biochemical mechanism. |
| GO:0005199 structural constituent of cell wall | ISS file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md | NEW | Summary: ENOD2 is a secreted, very proline-rich protein of the hydroxyproline-rich cell-wall glycoprotein (HRGP/extensin) class, built from pentapeptide repeats - the molecular hallmark of a structural cell-wall constituent. This captures the genuinely supported molecular nature of the protein, which the current GOA set lacks entirely. Reason: The only current-GOA annotation for ENOD2 (cytoplasm, IBA) is misleading, and the retired "nodulation" term reflects expression rather than function. What IS supported is that ENOD2 is a structural cell-wall protein. The protein is described as a very proline-rich protein composed largely of pentapeptide repeats that strongly resembles soybean cell-wall glycoproteins, with a putative N-terminal signal peptide consistent with secretion to the apoplast/cell wall (van de Wiel et al. 1990, via the deep-research synthesis). UniProt independently flags the protein as a Precursor with a Signal feature, a long Disordered region and multiple Pro-residue compositional-bias segments, and places it in the "nodulin 75 family" / "Proline-rich_CW_protein" (IPR051308) family. "Structural constituent of cell wall" (GO:0005199) is the accurate molecular-function term for this protein class. Evidence is ISS (inferred from sequence/structural similarity to characterised proline-rich cell-wall glycoproteins); no direct biochemical structural assay exists for soybean ENOD2, so the annotation is appropriately conservative. Supporting Evidence: file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md Protein described as very proline-rich and built largely from pentapeptide repeats containing two prolines; strongly resembles soybean cell-wall glycoproteins file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md Soybean ENOD2 encodes a **very proline-rich protein** composed largely of **pentapeptide repeats**. UniProtKB:P08297 InterPro; IPR051308; Proline-rich_CW_protein. |
| GO:0005576 extracellular region | ISS file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md | NEW | Summary: ENOD2 is a secreted precursor (N-terminal signal peptide) of the proline-rich cell-wall protein class; its mature product is targeted to the apoplast / cell wall, i.e. the extracellular region. This is the correct localisation that should replace the erroneous "cytoplasm" IBA annotation. Reason: The best-supported localisation for ENOD2, based on the predicted N-terminal signal peptide and the proline-rich cell-wall protein class, is the secretory pathway leading to the apoplast/cell wall. UniProt annotates SIGNAL 1..25 and treats the entry as a Precursor. "Extracellular region" (GO:0005576) is the conservative, well-supported cellular-component term; the more specific apoplast (GO:0048046) and plant-type cell wall (GO:0009505) are also supported by the protein class and are proposed as candidate refinements. Evidence is ISS because the localisation rests on sequence features and protein-class inference rather than a direct protein-localisation experiment for soybean ENOD2. Supporting Evidence: file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md the best-supported localization with the available evidence is: **secretory pathway → apoplast/cell wall** in **nodule parenchyma (inner cortex) cells** and cells associated with the nodule-root vascular connection. file:SOYBN/ENOD2A/ENOD2A-deep-research-falcon.md A putative N-terminal signal peptide supports secretion of ENOD2 to the cell wall / apoplast UniProtKB:P08297 SIGNAL 1..25 |
Loading supporting content…
Download this section (compressed HTML)Q: Does the soybean ENOD2 protein (not just its mRNA) localise to the cell wall / apoplast of nodule parenchyma cells, and is it hydroxylated/glycosylated as predicted for an HRGP-class protein?
Suggested experts: Ton Bisseling
Q: Does loss of function of ENOD2A/ENOD2B (e.g. CRISPR knockout of the tandem locus) affect nodule parenchyma structure, the nodule oxygen-diffusion barrier, or nitrogen-fixation efficiency in soybean?
Suggested experts: Ton Bisseling
Q: Is ENOD2 expression a downstream marker of inner-cortex differentiation, or does the ENOD2 cell-wall protein itself feed back on parenchyma cell-wall assembly?
Suggested experts: Henk Franssen
Experiment: Raise antibodies against the recombinant ENOD2 mature repeat region and perform immuno-electron-microscopy / immunolocalisation on soybean nodule sections to determine whether the protein is deposited in the cell walls of nodule parenchyma cells.
Hypothesis: ENOD2 protein accumulates in the cell wall / apoplast of nodule inner-cortex (parenchyma) cells, consistent with its predicted signal peptide and HRGP-class architecture.
Type: protein immunolocalisation
Experiment: Generate CRISPR/Cas9 knockouts of the tandem ENOD2A/ENOD2B locus in soybean and characterise nodule anatomy, parenchyma cell-wall ultrastructure, intranodular oxygen profiles (microelectrode) and acetylene-reduction nitrogen-fixation activity.
Hypothesis: ENOD2 contributes structurally to nodule parenchyma cell walls and the oxygen-diffusion barrier; its loss perturbs parenchyma morphology and/or the oxygen gradient protecting nitrogenase.
Type: loss-of-function genetics with nodule phenotyping
Experiment: Express ENOD2 in a heterologous system and assay post-translational modification (prolyl hydroxylation, arabinosylation) and cross-linking behaviour characteristic of extensin/HRGP cell-wall proteins.
Hypothesis: ENOD2 undergoes HRGP-type hydroxylation/glycosylation and can be incorporated into a cross-linked cell-wall network, supporting a structural cell-wall role.
Type: biochemical post-translational-modification assay
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)